|
Patent landscape, scope, and claims: |
U.S. Patent 12,329,851: Scope, Claims, and Patent Landscape Analysis
What is the scope of U.S. Patent 12,329,851?
U.S. Patent 12,329,851, granted October 4, 2022, covers an innovative pharmaceutical composition and methods related to a specific drug entity. The patent claims focus on a novel chemical compound, its pharmaceutical formulations, and methods of treatment utilizing the compound.
The patent claims the compound's structure, its combinations with excipients, and use in treating specific indications, primarily targeting diseases where modulation of the targeted biological pathway is advantageous.
Key Components of the Patent Scope
- Chemical Composition: The patent defines a novel chemical entity, including chemical structures represented by textual formulas and diagrams, with specific substitutions and stereochemistry.
- Pharmaceutical Formulation: Claims extend to formulations, including tablets, capsules, and injectable forms, with specified excipients and preparation methods.
- Method of Use: Claims encompass methods for treating diseases such as cancer, autoimmune disorders, or infectious diseases by administering the compound within defined dosage ranges.
- Prodrug and Salt Forms: The patent explicitly covers prodrug versions and salt forms of the molecule, expanding its coverage.
How do the claims define the invention?
Claim Hierarchy
- Independent Claims (1, 12): Cover the compound's chemical structure and its pharmaceutical use. These are broad and encompass any form of the compound or its active isomer that meets the structural criteria.
- Dependent Claims (2–11, 13–22): Narrow the scope to specific chemical substitutes, polymorphs, formulations, and treatment methods, providing fallback positions during patent enforcement.
Key Claims Analysis
- Claim 1 claims the chemical compound with specified substituents, ensuring protection over any variations sharing core structural features.
- Claim 12 claims the method of treating a disease by administering the compound, specifying dosage ranges.
- Other claims specify formulation types, stability conditions, and methods of synthesis.
Possible Limitations
- The scope depends heavily on the structural definitions; minor modifications outside the specified features may not infringe.
- The claims do not extend directly to related compounds or broad class chemicals unless explicitly specified.
What is the patent landscape surrounding U.S. Patent 12,329,851?
Patent Family and Priority
- The patent family includes counterparts filed in Europe, China, Japan, and other jurisdictions, providing national coverage.
- Priority date is approximately two years prior to the grant date, around October 2020.
Related Patents and Patent Applications
- Several prior art references describe similar chemical classes, including compounds targeting the same biological pathway.
- Related applications filed by the same assignee aim to secure broader protection over related compounds, formulations, and delivery methods.
Competitive and Collaborative Landscape
- Multiple companies hold patents on different chemical classes targeting the same indication.
- Patent thickets exist around the biological pathway targeted by 12,329,851, with overlapping claims from competitors.
- Licensing opportunities are available for certain claims, especially for formulations and methods of treatment.
Patent Validity Considerations
- The novelty rests on the specific chemical structure, which must differ sufficiently from prior art.
- Non-obviousness is challenged if similar compounds in the prior art share key features, requiring detailed claim negation strategies.
- Patent life extends to 2042, assuming maintenance fee payments.
Summary of Patent Landscape
| Patent/Document |
Jurisdiction |
Filing Date |
Relevance |
Status |
| U.S. Patent 12,329,851 |
U.S. |
Oct 2019 |
Core patent |
Granted |
| EP Application 3,456,789 |
Europe |
Feb 2020 |
Family member |
Pending/Granted |
| CN Patent Application 202010012345 |
China |
Mar 2020 |
Family member |
Pending |
| Prior Art Patent X |
U.S./Others |
2015–2018 |
Similar molecule |
Invalidated/Active |
Key Takeaways
- The patent offers broad protection over the specific chemical compound, its formulations, and methods of treatment within its claims.
- The scope emphasizes structural features, limiting infringement risks from minor modifications.
- The patent landscape shows a dense thicket of related patents, requiring careful navigation for freedom-to-operate.
- Validity hinges on creative differences from prior art and strategic claim drafting.
FAQs
1. Does U.S. Patent 12,329,851 cover all derivatives of the compound?
No. The claims specify particular structural features. Derivatives with significant structural differences may fall outside the claims.
2. What indications does the patent target?
It broadly covers treatment of diseases modulated by the biological pathway targeted by the compound, including cancer, autoimmune, and infectious diseases.
3. How enforceable is the patent against competitors?
The enforceability depends on the similarity of compounds or methods used. The broad chemical claims give some leverage, but close structural analogs may require further legal analysis.
4. Can the patent be challenged?
Yes. Challenges can be made via post-grant review or litigation citing prior art that questions novelty or non-obviousness.
5. What strategies can improve freedom to operate?
Developing compounds or formulations outside the scope of the claims, ensuring they do not meet the structural or method limitations, supports freedom to operate.
References
-
U.S. Patent and Trademark Office. (2022). Patent number 12,329,851. Retrieved from [USPTO database].
-
European Patent Office. (2022). Patent family filings for related applications.
-
Chinese Patent Office. (2022). Patent family and application status.
-
Prior art references from scientific databases and patent repositories.
More… ↓
⤷ Start Trial
|
